Amgen Selling Japanese Rights to Some Drugs
171103
Biotechnology giant Amgen is selling the Japanese rights to some drugs to Takeda Pharmaceutical of Japan in a deal that might bring Amgen more than $1 billion.
747542
ID Biomedical Corp. (IDB.TO: Quote, Profile, Research) (IDBE.O: Quote, Profile, Research) signed a US distribution deal for its Fluviral drug that could reap sales
351992
In the latest endorsement of a science technique discovered at the University of Massachusetts, the international drug giant Roche signed a $331 million deal with Alnylam Pharmaceuticals Inc. of Cambridge for the rights to develop drugs using RNA interference.
297779
Shares of SuperGen Inc.  jumped more than 24 percent in trading before the market opened on Wednesday after MGI Pharma Inc.  said it would take a &#36;40 million stake in the company as part of a cancer drug license deal.
518270
AMSTERDAM -- Schering-Plough Corp. agreed to buy Akzo Nobel NV's drug-making division Organon for $14.4 billion to gain the world's third-largest maker of birth-control pills and a stable of experimental medicines.
727152
New developments are brewing at the pharmaceutical.
178334
The Motley Fool - Pharmaceutical investors often forget that places beyond the United States and European Union have their own regulatory bodies that approve drugs -- and that some of these markets can be quite lucrative. Canada, Japan, and Australia are home to some of the biggest economies in the world, and they all have their own independent drug-regulation entities.
478980
Shares of German drugmaker Merck KGaA climbed sharply Tuesday after the company released successful new study results for its cancer drug Erbitux. Shares of biotechnology company ImClone, which developed the drug, soared nearly 24 percent in the U.S.
726765
Amgen Inc. has added a warning to  its anemia drug, Aranesp, for kidney dialysis and cancer  patients after studies on similar drugs showed higher doses can  cause blood clots and death, the company said a letter released  on Friday.
411592
It makes sense for the drugmaker to sell millions more shares right now.
36924
By Kyodo News International, Tokyo  Sep. 7--OSAKA -- Takeda Pharmaceutical Co., Japan's largest drug maker,  is planning to build a new laboratory by March 2011 to enhance its development  of new drugs, company sources said Thursday.
723657
Could a jointly marketed drug lead to a joint company? Ireland&#39;s Sunday Tribune said yesterday that US pharmaceuticals company Biogen Idec (nasdaq: BIIB - news - people ) was looking to make an all-stock bid
256991
Medicare payment policies for Amgen Inc.'s antianemia drug Epogen were criticized yesterday during a congressional hearing as "perverse" and potentially dangerous to kidney dialysis patients.
145826
American Oriental Bioengineering makes an acquisition.
39231
Shares of SuperGen Inc. SUPG.O  jumped more than 24 percent in trading before the market opened  on Wednesday after MGI Pharma Inc. MOGN.O said it would take  a $40 million stake in the company as part of a cancer drug  license deal.
303789
Schering-Plough and Bayer have announced an agreement under which New Jersey-based Schering will attain US marketing rights to Bayer HealthCareâs primary care pharmaceutical products, including the antibiotics Avelox (moxifloxacin HCL) and Cipro
665690
The developing biopharmaceutical company announces a share offering.